To investigate if Helicobacter pylori (HP) eradication could make an effective and long-lasting improvement in the pharmacokinetic and clinical response to l-dopa in patients with Parkinson disease (PD) and motor fluctuations.
Pierantozzi, M., Pietroiusti, A., Brusa, L., Galati, S., Stefani, A., Lunardi, G., et al. (2006). Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations. NEUROLOGY, 66(12), 1824-1829 [10.1212/01.wnl.0000221672.01272.ba].
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations
PIERANTOZZI, MARIANGELA;PIETROIUSTI, ANTONIO;STEFANI, ALESSANDRO;SANCESARIO, GIUSEPPE;BERNARDI, GIORGIO;MAGRINI, ANDREA;STANZIONE, PAOLO;GALANTE, ALBERTO
2006-06-27
Abstract
To investigate if Helicobacter pylori (HP) eradication could make an effective and long-lasting improvement in the pharmacokinetic and clinical response to l-dopa in patients with Parkinson disease (PD) and motor fluctuations.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
neurology 2006 HP.pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
507.09 kB
Formato
Adobe PDF
|
507.09 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
